glp 1 coverage 2025 GLP-1 RA prior authorization and out-of-pocket costs rise from 2020 to glp1 #employer #coverage #benefits #trends

Regulatory guidance still recommends stopping the drug if pancreatitis is suspected, but theres no strong evidence of a direct link

92 Cardiovascular Outcome Trials of GLP-1RAs in Patients with HFpEF In contrast to its use in patients with HFrEF, GLP-1 RA use in patients with HFpEF is associated with significant improvements in symptoms, weight loss and enhanced quality of life

GLP-1 side effects and safety considerations As with any medication, you need to be aware of the potential side effects when taking a GLP-1

An evidence level has been assigned to each risk category, based on RCT and observational data, as well as NICE/SIGN guidelines and the licensed indication for each GLP-1 RA therapy

Here is how to optimize that partnership